New York Health Center COVID-19 Survey Summary Report

Latest data from September 24, 2021

Number of Health Center respondents = 46 (73% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, antigen)1 36,120
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, antigen) 74.40%
Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen)1 2,051
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen) 56.41%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, antigen)2 Patients Tested Positive, Virus Detection (PCR, antigen)2
White, Non-Hispanic/Latino Patients 17.79% 31.69%
White, Hispanic/Latino Patients 6.64% 7.12%
Black/African American, Non-Hispanic/Latino Patients 20.48% 14.97%
Black/African American, Hispanic/Latino Patients 2.29% 1.51%
Asian Patients3 3.78% 2.83%
American Indian/Alaska Native Patients3 0.31% 0.34%
Native Hawaiian/Other Pacific Islander Patients3 0.43% 0.54%
Patients with More than one race3 2.21% 1.56%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 15.55% 12.14%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 8.50% 4.83%
Unreported/Refused to Report Race and Ethnicity 22.02% 22.48%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 12,192
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 92.40%
COVID-19 Immunization Series Completed 22,420
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 96.66%
COVID-19 Immunization Series Additional 381
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 65.29%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 5.81% 2.90% 28.61%
White, Hispanic/Latino Patients 9.01% 5.79% 4.72%
Black/African American, Non-Hispanic/Latino Patients 24.42% 13.22% 17.59%
Black/African American, Hispanic/Latino Patients 3.58% 1.90% 1.31%
Asian Patients3 1.80% 0.93% 4.72%
American Indian/Alaska Native Patients3 0.49% 0.25% 4.72%
Native Hawaiian/Other Pacific Islander Patients3 0.48% 0.30% 0.26%
Patients with More than one race3 6.65% 46.81% 0.79%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 24.17% 14.65% 19.69%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 4.36% 2.46% 4.72%
Unreported/Refused to Report Race and Ethnicity 19.22% 10.80% 12.86%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, antigen)

Metrics Value
Less Than 1 Hour 13.04%
1 to 24 Hours 23.91%
More Than 24 Hours 60.87%
N/A 2.17%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 13.04%
Staffing to administer the vaccine 34.78%
Vaccine confidence 47.83%
Vaccine storage capacity 0.00%
Vaccine supply 2.17%
Other 6.52%
None 23.91%

Operations and Staff

Metrics Value
Health Center Weekly Visits Compared to Pre-COVID 19 Weekly Visits 94.57%
Average Percent of Health Center Visits Conducted Virtually 16.09%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 32.61%
Number of Mobile Van Sites 10
Number of Pop-up Clinics 68
Number of School-Based Vaccination Sites 4

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 6.52%
Refer patients to another organization that provides monoclonal antibody therapies 34.78%
None 58.70%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 13.04%
Patient awareness/education 8.70%
Staffing capacity 26.09%
Therapy administration/onsite logistics 32.61%
Other 6.52%
None 41.30%

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

Date Last Reviewed:  October 2021